Reply to "Mepolizumab in patients with eosinophilic granulomatosis with polyangiitis in remission: What is the right dose?"

被引：2
|
作者：
Caminati, Marco [1 ,2 ]
Crisafulli, Ernesto [2 ,3 ,4 ]
Lunardi, Claudio [1 ,2 ]
Micheletto, Claudio [5 ]
Festi, Giuliana [5 ]
Maule, Matteo [6 ]
Giollo, Alessandro [2 ,7 ]
Orsolini, Giovanni [7 ]
Senna, Gianenrico [1 ,2 ,8 ,9 ]
机构：
[1] Univ Verona, Dept Med, Verona, Italy
[2] Verona Univ Hosp, Verona, Italy
[3] Univ Verona, Dept Med, Resp Med Unit, Verona, Italy
[4] Univ Verona, Dept Med, Sect Internal Med, Verona, Italy
[5] Integrated Univ Hosp, Resp Unit, Cardiothorac Dept, Verona, Italy
[6] Univ Verona, Specializat Course Allergy & Clin Immunol, Dept Med, Verona, Italy
[7] Univ Verona, Verona Univ Hosp, Dept Med, Div Rheumatol, Verona, Italy
[8] Verona Univ Hosp, Allergy Unit, Verona, Italy
[9] Verona Univ Hosp, Asthma Ctr, Verona, Italy
来源：
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE | 2021年 / 9卷 / 07期
关键词：
D O I：
10.1016/j.jaip.2021.04.029
中图分类号：
R392 [医学免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页码：2943 / 2944
页数：2
相关论文
共 50 条
  • [1] Mepolizumab in patients with eosinophilic granulomatosis with polyangiitis in remission: What is the right dose?
    Akdime, Florie
    Puechal, Xavier
    Roche, Nicolas
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE, 2021, 9 (07): : 2942 - 2943
  • [2] Mepolizumab in patients with eosinophilic granulomatosis with polyangiitis Reply
    Wechsler, Michael E.
    Pouliquen, Isabelle
    Steinfeld, Jonathan
    Bradford, Eric S.
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2019, 144 (02) : 622 - 622
  • [3] Mepolizumab in eosinophilic granulomatosis with polyangiitis Reply
    Gomez, Carlos Romero
    Gutierrez, Marla del Mar Ayala
    Negrin, Halbert Hernandez
    MEDICINA CLINICA, 2024, 162 (03): : 141 - 141
  • [4] Low Dose Mepolizumab in Eosinophilic Granulomatosis with Polyangiitis
    Jackson, D. J.
    Green, L.
    Fernandes, M.
    Bolton, M.
    Roxas, C.
    D'Ancona, G.
    Agarwal, S.
    Kent, B. D.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2018, 197
  • [5] Mepolizumab in patients with eosinophilic granulomatosis with polyangiitis
    Moiseev, Sergey
    Zagvozdkina, Eugenia
    Kazarina, Viktoria
    Bulanov, Nikolai
    Novikov, Pavel
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2019, 144 (02) : 621 - 621
  • [6] Efficacy of Increasing the Dose of Mepolizumab in Eosinophilic Granulomatosis with Polyangiitis
    Pallotti, Federica
    Bonniaud, Philippe
    Smets, Perrine
    Habib, Stephanie
    Perier, Amandine
    Deroux, Alban
    Mankikian, Julie
    Neel, Antoine
    Rousselin, Clementine
    Seror, Raphaele
    Taille, Camille
    Crickx, Etienne
    La Croix, Candice
    Blanche, Philippe
    Guillevin, Loic
    Puechal, Xavier
    Terrier, Benjamin
    ARTHRITIS & RHEUMATOLOGY, 2024, 76 : 3259 - 3261
  • [7] Low Dose of Mepolizumab in Treatment of Eosinophilic Granulomatosis with Polyangiitis
    Maia, A. P.
    San Martin, S. R.
    Erazo, A. C. E.
    Toledo, A. P.
    Oliveira, E. P.
    Assuncao, G. L.
    Barbas, C. S.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2020, 201
  • [8] Mepolizumab for eosinophilic granulomatosis with polyangiitis
    Loïc Guillevin
    Nature Reviews Rheumatology, 2017, 13 : 518 - 519
  • [9] Asthma remission in patients with eosinophilic granulomatosis with polyangiitis (EGPA) following treatment with benralizumab or mepolizumab
    Bourdin, Arnaud
    Wechsler, Michael E.
    Jackson, David J.
    Siddiqui, Salman
    Baudy, Peter
    Menzies-Gow, Andrew
    Necander, Sofia
    Shavit, Anat
    Walton, Claire
    EUROPEAN RESPIRATORY JOURNAL, 2024, 64
  • [10] Asthma remission in patients with eosinophilic granulomatosis with polyangiitis (EGPA) following treatment with benralizumab or mepolizumab
    Bourdin, A.
    Wechsler, M. E.
    Jackson, D. J.
    Siddiqu, S.
    Baudy, P.
    Menzies-Gow, A.
    Shavit, A.
    Necander, S.
    Walton, C.
    ALLERGOLOGIE, 2024, 47 (09)
12345